nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloropyramine—PTK2—Internalization of ErbB1—SH3KBP1—adrenal gland cancer	0.0498	0.0498	CbGpPWpGaD
Chloropyramine—PTK2—DCC mediated attractive signaling—CDC42—adrenal gland cancer	0.0387	0.0387	CbGpPWpGaD
Chloropyramine—PTK2—Nongenotropic Androgen signaling—GNRH1—adrenal gland cancer	0.0378	0.0378	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—SPRY2—adrenal gland cancer	0.0293	0.0293	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—SH3KBP1—adrenal gland cancer	0.0274	0.0274	CbGpPWpGaD
Chloropyramine—PTK2—Alpha4 beta1 integrin signaling events—PRKACA—adrenal gland cancer	0.023	0.023	CbGpPWpGaD
Chloropyramine—PTK2—Nectin adhesion pathway—CDC42—adrenal gland cancer	0.021	0.021	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—DAXX—adrenal gland cancer	0.0205	0.0205	CbGpPWpGaD
Chloropyramine—PTK2—Nongenotropic Androgen signaling—CDC42—adrenal gland cancer	0.0205	0.0205	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events regulated by Ret tyrosine kinase—PRKACA—adrenal gland cancer	0.0201	0.0201	CbGpPWpGaD
Chloropyramine—PTK2—Netrin-mediated signaling events—CDC42—adrenal gland cancer	0.02	0.02	CbGpPWpGaD
Chloropyramine—PTK2—IGF1 pathway—IGF1R—adrenal gland cancer	0.0196	0.0196	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—CDC42—adrenal gland cancer	0.0174	0.0174	CbGpPWpGaD
Chloropyramine—PTK2—EPHB forward signaling—CDC42—adrenal gland cancer	0.0171	0.0171	CbGpPWpGaD
Chloropyramine—PTK2—EPHB-mediated forward signaling—CDC42—adrenal gland cancer	0.0164	0.0164	CbGpPWpGaD
Chloropyramine—PTK2—Netrin-1 signaling—CDC42—adrenal gland cancer	0.0161	0.0161	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—SH3KBP1—adrenal gland cancer	0.0156	0.0156	CbGpPWpGaD
Chloropyramine—PTK2—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.0156	0.0156	CbGpPWpGaD
Chloropyramine—PTK2—IGF1 pathway—BAD—adrenal gland cancer	0.0147	0.0147	CbGpPWpGaD
Chloropyramine—PTK2—RANKL/RANK Signaling Pathway—CDC42—adrenal gland cancer	0.013	0.013	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—PRKACA—adrenal gland cancer	0.0129	0.0129	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of actin dynamics for phagocytic cup formation—CDC42—adrenal gland cancer	0.0126	0.0126	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—CDC42—adrenal gland cancer	0.0109	0.0109	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—IGF1R—adrenal gland cancer	0.0108	0.0108	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—CDC42—adrenal gland cancer	0.0101	0.0101	CbGpPWpGaD
Chloropyramine—PTK2—Nectin adhesion pathway—CTNNB1—adrenal gland cancer	0.00966	0.00966	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CDC42—adrenal gland cancer	0.0096	0.0096	CbGpPWpGaD
Chloropyramine—PTK2—Fcgamma receptor (FCGR) dependent phagocytosis—CDC42—adrenal gland cancer	0.0095	0.0095	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—CDC42—adrenal gland cancer	0.00923	0.00923	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—SPRY2—adrenal gland cancer	0.0092	0.0092	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—BAD—adrenal gland cancer	0.00917	0.00917	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—PRKACA—adrenal gland cancer	0.00897	0.00897	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—CDC42—adrenal gland cancer	0.00881	0.00881	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—PRKACA—adrenal gland cancer	0.00846	0.00846	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.00844	0.00844	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—GNAS—adrenal gland cancer	0.0082	0.0082	CbGpPWpGaD
Chloropyramine—PTK2—Nanoparticle-mediated activation of receptor signaling—EGFR—adrenal gland cancer	0.00809	0.00809	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—CDC42—adrenal gland cancer	0.00803	0.00803	CbGpPWpGaD
Chloropyramine—PTK2—Apoptotic cleavage of cellular proteins—CTNNB1—adrenal gland cancer	0.00799	0.00799	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—BAD—adrenal gland cancer	0.00772	0.00772	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—CDC42—adrenal gland cancer	0.0076	0.0076	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by focal adhesion kinase—BRAF—adrenal gland cancer	0.00757	0.00757	CbGpPWpGaD
Chloropyramine—HRH1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0075	0.0075	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—CDC42—adrenal gland cancer	0.00718	0.00718	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—BAD—adrenal gland cancer	0.00705	0.00705	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—adrenal gland cancer	0.00694	0.00694	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0067	0.0067	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—BAD—adrenal gland cancer	0.0067	0.0067	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—BAD—adrenal gland cancer	0.00644	0.00644	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—CDC42—adrenal gland cancer	0.00643	0.00643	CbGpPWpGaD
Chloropyramine—PTK2—Internalization of ErbB1—EGFR—adrenal gland cancer	0.00633	0.00633	CbGpPWpGaD
Chloropyramine—PTK2—Apoptotic execution phase—CTNNB1—adrenal gland cancer	0.00622	0.00622	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—NR5A1—adrenal gland cancer	0.00601	0.00601	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00595	0.00595	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00584	0.00584	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—POMC—adrenal gland cancer	0.00552	0.00552	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—RB1—adrenal gland cancer	0.0055	0.0055	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—CDC42—adrenal gland cancer	0.00546	0.00546	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—BRAF—adrenal gland cancer	0.00545	0.00545	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TERT—adrenal gland cancer	0.00516	0.00516	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—BRAF—adrenal gland cancer	0.0051	0.0051	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—adrenal gland cancer	0.00508	0.00508	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—adrenal gland cancer	0.00502	0.00502	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00496	0.00496	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—CDC42—adrenal gland cancer	0.0048	0.0048	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—CTNNB1—adrenal gland cancer	0.00479	0.00479	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—EGFR—adrenal gland cancer	0.00478	0.00478	CbGpPWpGaD
Chloropyramine—HRH1—IL-4 Signaling Pathway—BAD—adrenal gland cancer	0.00459	0.00459	CbGpPWpGaD
Chloropyramine—HRH1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00449	0.00449	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—IGF1R—adrenal gland cancer	0.00448	0.00448	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—adrenal gland cancer	0.00441	0.00441	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00426	0.00426	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—EGFR—adrenal gland cancer	0.00417	0.00417	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.0041	0.0041	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—CTNNB1—adrenal gland cancer	0.00405	0.00405	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—adrenal gland cancer	0.00402	0.00402	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00402	0.00402	CbGpPWpGaD
Chloropyramine—PTK2—ErbB Signaling Pathway—TP53—adrenal gland cancer	0.00401	0.00401	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—BAD—adrenal gland cancer	0.00395	0.00395	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.00394	0.00394	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00378	0.00378	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00371	0.00371	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—MED12—adrenal gland cancer	0.00361	0.00361	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—CTNNB1—adrenal gland cancer	0.00349	0.00349	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	0.00347	0.00347	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—TP53—adrenal gland cancer	0.00338	0.00338	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—BAD—adrenal gland cancer	0.00335	0.00335	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—CTNNB1—adrenal gland cancer	0.0033	0.0033	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—SH3KBP1—adrenal gland cancer	0.00329	0.00329	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—EGFR—adrenal gland cancer	0.00321	0.00321	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—CDC42—adrenal gland cancer	0.00313	0.00313	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—SPARC—adrenal gland cancer	0.00306	0.00306	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—BRAF—adrenal gland cancer	0.00305	0.00305	CbGpPWpGaD
Chloropyramine—PTK2—Cell-Cell communication—CTNNB1—adrenal gland cancer	0.00299	0.00299	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00297	0.00297	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00265	0.00265	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—CTNNB1—adrenal gland cancer	0.0026	0.0026	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—PRKACA—adrenal gland cancer	0.00259	0.00259	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—PRKACA—adrenal gland cancer	0.00233	0.00233	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00229	0.00229	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00226	0.00226	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—CDC42—adrenal gland cancer	0.00224	0.00224	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—CTNNB1—adrenal gland cancer	0.00221	0.00221	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—CDC42—adrenal gland cancer	0.00219	0.00219	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00214	0.00214	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00213	0.00213	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—IGF2—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—GNAS—adrenal gland cancer	0.0021	0.0021	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00202	0.00202	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.002	0.002	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	0.00199	0.00199	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CDC42—adrenal gland cancer	0.00198	0.00198	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TP53—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—EGFR—adrenal gland cancer	0.00175	0.00175	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis—TP53—adrenal gland cancer	0.00173	0.00173	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—BAD—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—PRKACA—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TSHR—adrenal gland cancer	0.00122	0.00122	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00117	0.00117	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00116	0.00116	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CDC42—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—MEN1—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—EGFR—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—CTNNB1—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.001	0.001	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CTNNB1—adrenal gland cancer	0.000907	0.000907	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000877	0.000877	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—EGFR—adrenal gland cancer	0.000814	0.000814	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—BAD—adrenal gland cancer	0.000803	0.000803	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000793	0.000793	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	0.00079	0.00079	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CDC42—adrenal gland cancer	0.000744	0.000744	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000743	0.000743	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—EGFR—adrenal gland cancer	0.000719	0.000719	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—IGF2—adrenal gland cancer	0.000717	0.000717	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—GNAS—adrenal gland cancer	0.000711	0.000711	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000694	0.000694	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000693	0.000693	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000686	0.000686	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—TP53—adrenal gland cancer	0.00067	0.00067	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000663	0.000663	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000631	0.000631	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000628	0.000628	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	0.000612	0.000612	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000602	0.000602	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TERT—adrenal gland cancer	0.000597	0.000597	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	0.000575	0.000575	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CTNNB1—adrenal gland cancer	0.000528	0.000528	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—BAD—adrenal gland cancer	0.000519	0.000519	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—POMC—adrenal gland cancer	0.000479	0.000479	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—BRAF—adrenal gland cancer	0.000473	0.000473	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000447	0.000447	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000439	0.000439	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—EGFR—adrenal gland cancer	0.000419	0.000419	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	0.000406	0.000406	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.000372	0.000372	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000359	0.000359	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.000356	0.000356	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000347	0.000347	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000342	0.000342	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	0.000299	0.000299	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—EGFR—adrenal gland cancer	0.000271	0.000271	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	0.00026	0.00026	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	0.00024	0.00024	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	0.000237	0.000237	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000229	0.000229	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TP53—adrenal gland cancer	0.000227	0.000227	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000171	0.000171	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	0.000135	0.000135	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	0.000114	0.000114	CbGpPWpGaD
